By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The International Severe Adverse Events Consortium (iSAEC) will partner with the HMO Research Network (HMORN) to use electronic medical records to identify patients with genetic markers that put them at risk for having adverse reactions to drug treatments, iSAEC said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.